Status:
RECRUITING
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Lead Sponsor:
Mansoura University Hospital
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-70 years
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormaliti...
Detailed Description
Chronic Obstructive Pulmonary Disease(COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalitie...
Eligibility Criteria
Inclusion
- Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria
Exclusion
- Patients with known allergic diseases before enrollment
- Patients with associated other chronic respiratory disorders
- Patients with significant comorbidities that could influence respiratory function.
- Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment.
Key Trial Info
Start Date :
July 14 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06518473
Start Date
July 14 2024
End Date
December 15 2025
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed AbdElmoniem
Al Mansurah, Egypt, 35516